(SLGN) Silgan Holdings - NYSE
Sector: Consumer Cyclical | Industry: Packaging & Containers | Exchange: NYSE (USA) | Market Cap: 4.402m USD | Total Return: -21.2% in 12m
Avg Turnover: 34.0M
EPS Trend: 51.9%
Qual. Beats: 2
Rev. Trend: 69.8%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Silgan Holdings (NYSE: SLGN) is a U.S.-based manufacturer of rigid packaging solutions serving consumer goods markets both domestically and internationally. Founded in 1987 and headquartered in Norwalk, Connecticut, the company operates through three reporting segments: Dispensing and Specialty Closures, Metal Containers, and Custom Containers. Its mid-cap market capitalization of approximately $4.4 billion places it within the Materials sector under the Metal, Glass & Plastic Containers sub-industry.
The companys Dispensing and Specialty Closures segment produces integrated dispensing packaging solutions, proprietary metal and plastic specialty closures, and capping/sealing equipment with detection systems, serving fragrance, beauty, food, beverage, personal care, healthcare, home care, and lawn and garden end markets. The Metal Containers segment supplies steel and aluminum containers for food processors, including pet food, soup, vegetables, proteins, and other shelf-stable food products. The Custom Containers segment produces custom-designed polyethylene and PET containers, thermoformed barrier and non-barrier bowls and trays, and plastic caps, sifters, and fitments for food and household products.
Silgan distributes its products through a direct sales force, a network of distributors, and an online shopping catalog. As a supplier to consumer packaged goods companies, its business model is tied to the stable, recurring demand characteristics typical of the rigid packaging industry, where long-standing customer relationships and high switching costs for packaging formats support ongoing volume-based revenue. The company has been publicly traded since its 1997 IPO.
- Dispensing and Specialty Closures acquisitions drive margin expansion
- Pet food and food-at-home demand boost Metal Containers revenue
- Resin and steel input cost volatility pressures packaging margins
| Net Income: 307.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 5.64 > 1.0 |
| NWC/Revenue: 8.64% < 20% (prev 5.20%; Δ 3.44% < -1%) |
| CFO/TA 0.13 > 3% & CFO 1.18b > Net Income 307.8m |
| Net Debt (4.42b) to EBITDA (1.00b): 4.40 < 3 |
| Current Ratio: 1.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (105.9m) vs 12m ago -1.34% < -2% |
| Gross Margin: 16.65% > 18% (prev 17.63%; Δ -0.99% > 0.5%) |
| Asset Turnover: 77.91% > 50% (prev 68.48%; Δ 9.43% > 0%) |
| Interest Coverage Ratio: 3.57 > 6 (EBIT TTM 678.8m / Interest Expense TTM 190.1m) |
| A: 0.07 (Total Current Assets 2.97b - Total Current Liabilities 2.36b) / Total Assets 9.32b |
| B: 0.39 (Retained Earnings 3.65b / Total Assets 9.32b) |
| C: 0.08 (EBIT TTM 678.8m / Avg Total Assets 9.05b) |
| D: 0.33 (Book Value of Equity 2.32b / Total Liabilities 7.00b) |
| Altman-Z'' = 2.56 = A |
| DSRI: 0.97 (Receivables 1.16b/1.01b, Revenue 7.05b/6.00b) |
| GMI: 1.06 (GM 17.63% / 16.65%) |
| AQI: 0.97 (AQ_t 0.43 / AQ_t-1 0.44) |
| SGI: 1.17 (Revenue 7.05b / 6.00b) |
| TATA: -0.09 (NI 307.8m - CFO 1.18b) / TA 9.32b) |
| Beneish M = -2.89 (Cap -4..+1) = A |
As of June 21, 2026, the stock is trading at USD 41.65 with a total of 1,193,100 shares traded.
Over the past week, the price has changed by +3.56%,
over one month by +12.93%,
over three months by +7.18% and
over the past year by -21.23%.
Silgan Holdings has received a consensus analysts rating of 4.42. Therefore, it is recommended to buy SLGN.
- StrongBuy: 8
- Buy: 2
- Hold: 1
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 53.2 | 27.7% |
P/E Trailing = 15.5993
P/E Forward = 10.9649
P/S = 0.6692
P/B = 1.8967
P/EG = 0.8384
Revenue TTM = 7.05b USD
EBIT TTM = 678.8m USD
EBITDA TTM = 1.00b USD
Long Term Debt = 3.67b USD (from longTermDebt, last quarter)
Short Term Debt = 988.3m USD (from shortTermDebt, last quarter)
Debt = 4.86b USD (from shortLongTermDebtTotal, last quarter) + Leases 195.7m
Net Debt = 4.42b USD (calculated: Debt 4.86b - CCE 435.4m)
Enterprise Value = 8.82b USD (4.40b + Debt 4.86b - CCE 435.4m)
Interest Coverage Ratio = 3.57 (Ebit TTM 678.8m / Interest Expense TTM 190.1m)
EV/FCF = 10.23x (Enterprise Value 8.82b / FCF TTM 862.0m)
FCF Yield = 9.77% (FCF TTM 862.0m / Enterprise Value 8.82b)
FCF Margin = 12.23% (FCF TTM 862.0m / Revenue TTM 7.05b)
Net Margin = 4.37% (Net Income TTM 307.8m / Revenue TTM 7.05b)
Gross Margin = 16.65% ((Revenue TTM 7.05b - Cost of Revenue TTM 5.87b) / Revenue TTM)
Gross Margin QoQ = 17.02% (prev 17.21%)
Tobins Q-Ratio = 0.95 (Enterprise Value 8.82b / Total Assets 9.32b)
Interest Expense / Debt = 3.91% (Interest Expense 190.1m / Debt 4.86b)
Taxrate = 28.51% (124.7m / 437.6m)
NOPAT = 485.3m (EBIT 678.8m * (1 - 28.51%))
Current Ratio = 1.26 (Total Current Assets 2.97b / Total Current Liabilities 2.36b)
Debt / Equity = 2.09 (Debt 4.86b / totalStockholderEquity, last quarter 2.32b)
Debt / EBITDA = 4.40 (Net Debt 4.42b / EBITDA 1.00b)
Debt / FCF = 5.13 (Net Debt 4.42b / FCF TTM 862.0m)
Total Stockholder Equity = 2.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.40% (Net Income 307.8m / Total Assets 9.32b)
RoE = 13.54% (Net Income TTM 307.8m / Total Stockholder Equity 2.27b)
RoCE = 11.42% (EBIT 678.8m / Capital Employed (Equity 2.27b + L.T.Debt 3.67b))
RoIC = 6.39% (NOPAT 485.3m / Invested Capital 7.60b)
WACC = 4.89% (E(4.40b)/V(9.26b) * Re(7.20%) + D(4.86b)/V(9.26b) * Rd(3.91%) * (1-Tc(0.29)))
Discount Rate = 7.20% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -4.49 | Cagr: -0.42%
[DCF] Terminal Value 77.97% ; FCFF base≈643.6m ; Y1≈737.7m ; Y5≈1.09b
[DCF] Fair Price = 112.8 (EV 16.3b - Net Debt 4.42b = Equity 11.9b / Shares 105.7m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 51.88 | EPS CAGR: 3.30% | SUE: 1.76 | # QB: 2
Revenue Correlation: 69.77 | Revenue CAGR: 5.95% | SUE: 0.28 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.96 | Chg30d=-0.60% | Revisions=-47% | Analysts=11
EPS next Quarter (2026-09-30): EPS=1.28 | Chg30d=+0.80% | Revisions=+7% | Analysts=11
EPS current Year (2026-12-31): EPS=3.81 | Chg30d=+1.50% | Revisions=+47% | GrowthEPS=+2.4% | GrowthRev=+5.9%
EPS next Year (2027-12-31): EPS=4.08 | Chg30d=+0.61% | Revisions=+9% | GrowthEPS=+7.3% | GrowthRev=+2.1%
[Analyst] Revisions Ratio: -47%